Literature DB >> 17109177

Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria.

Xiu-Ling Wang1, Ho-Jin Kim, Su-Il Kang, Su-Il Kim, Hor-Gil Hur.   

Abstract

An anaerobic incubation mixture of two bacterial strains Eggerthella sp. Julong 732 and Lactobacillus sp. Niu-O16, which have been known to transform dihydrodaidzein to S-equol and daidzein to dihydrodaidzein respectively, produced S-equol from daidzein through dihydrodaidzein. The biotransformation kinetics of daidzein by the mixed cultures showed that the production of S-equol from daidzein was significantly enhanced, as compared to the production of S-equol from dihydrodaidzein by Eggerthella sp. Julong 732 alone. The substrate daidzein in the mixed culture was almost completely converted to S-equol in 24 h of anaerobic incubation. The increased production of S-equol from daidzein by the mixed culture is likely related to the increased bacterial numbers of Eggerthella sp. Julong 732. In the mixture cultures, the growth of Eggerthella sp. Julong 732 was significantly increased while the growth of Lactobacillus sp. Niu-O16 was suppressed as compared to either the single culture of Eggerthella sp. Julong 732 or Lactobacillus sp. Niu-O16. This is the first report in which two metabolic pathways to produce S-equol from daidzein by a mixed culture of bacteria isolated from human and bovine intestinal environments were successfully linked under anaerobic conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109177     DOI: 10.1007/s00203-006-0183-8

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  20 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

Review 2.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

Review 3.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

Review 4.  Bioavailability of the polyphenols: status and controversies.

Authors:  Massimo D'Archivio; Carmelina Filesi; Rosaria Varì; Beatrice Scazzocchio; Roberta Masella
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

5.  The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

Authors:  Kenneth Dr Setchell; Xueheng Zhao; Pinky Jha; James E Heubi; Nadine M Brown
Journal:  Am J Clin Nutr       Date:  2009-08-26       Impact factor: 7.045

6.  Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine.

Authors:  Anastasia Matthies; Thomas Clavel; Michael Gütschow; Wolfram Engst; Dirk Haller; Michael Blaut; Annett Braune
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

7.  Influence of fructooligosaccharide on pharmacokinetics of isoflavones in postmenopausal women.

Authors:  Supanimit Teekachunhatean; Sujitra Techatoei; Noppamas Rojanasthein; Maleeya Manorot; Chaichan Sangdee
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-26       Impact factor: 2.629

Review 8.  Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.

Authors:  Aleksandra Duda-Chodak; Tomasz Tarko; Paweł Satora; Paweł Sroka
Journal:  Eur J Nutr       Date:  2015-02-12       Impact factor: 5.614

9.  Soy consumption during menopause.

Authors:  S Bolca; M Bracke; H Depypere
Journal:  Facts Views Vis Obgyn       Date:  2012

10.  Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.

Authors:  Mariko Uehara
Journal:  J Clin Biochem Nutr       Date:  2013-05-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.